#14 - Tyler Golato - Decentralizing Drug Development For The Greater Public Good
09/17/21 • 47 min
Today is a very special episode where I will be discussing Biotech and Blockchain. Now you might be asking yourself - how do blockchain and biotech have anything to do with each other? That's exactly what i thought as well when I first heard of VitaDao. But after my conversation today I'm convinced that this is a collision of industries that was absolutely necessary. Vitadao is taking the world of crypto, and the world of BioTech and smashing them together in an explosion of innovation.
VitaDao is a completely decentralized autonomous organization... also know as a DAO... now there's a high likelihood that that sounds like a foreign language, and that a lot of you have never heard of a decentralized autonomous organization.. fear not, we go deep into exactly what that means in this episode.
VitaDao is allowing any investor to invest in the absolute cutting edge BioTech technologies... the type of technologies that have so much potential, but carry so much risk, that the typical institutional investor or VC will pass on.
This conversation blew me away... just wait until you hear what they're doing with BioTech IP and NFTs. I don't want to spoil too much but this is an episode you won't want to miss.
Podcast notes and transcript available here: https://simplebiotechpodcast.com/tyler-golato-vitadao
-James Ruhle, SimpleBioTechPodcast.com
Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech
If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle
Today is a very special episode where I will be discussing Biotech and Blockchain. Now you might be asking yourself - how do blockchain and biotech have anything to do with each other? That's exactly what i thought as well when I first heard of VitaDao. But after my conversation today I'm convinced that this is a collision of industries that was absolutely necessary. Vitadao is taking the world of crypto, and the world of BioTech and smashing them together in an explosion of innovation.
VitaDao is a completely decentralized autonomous organization... also know as a DAO... now there's a high likelihood that that sounds like a foreign language, and that a lot of you have never heard of a decentralized autonomous organization.. fear not, we go deep into exactly what that means in this episode.
VitaDao is allowing any investor to invest in the absolute cutting edge BioTech technologies... the type of technologies that have so much potential, but carry so much risk, that the typical institutional investor or VC will pass on.
This conversation blew me away... just wait until you hear what they're doing with BioTech IP and NFTs. I don't want to spoil too much but this is an episode you won't want to miss.
Podcast notes and transcript available here: https://simplebiotechpodcast.com/tyler-golato-vitadao
-James Ruhle, SimpleBioTechPodcast.com
Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech
If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle
Previous Episode
#13 - Nora Khaldi - How Nuritas is using AI to Unlock the Miraculous Benefits in the Food We Eat Every Day
Locked in every bite of food we take is a universe of hidden potential. Potential to cure disease, help our sleep, and improve our mood just to name a few. The food we eat has a galaxy of molecules we call peptides, these peptides have limitless possibilities that get destroyed by the black hole we call our digestive system. These peptides have some truly miraculous healing qualities, but because of the extreme weakness in their bioavailability, to date humans have not been able to experience the benefits.
Enter Nuritas - a company focusing on finding these miraculous peptides using AI technology, and extracting them from the food to become more bioavailable, essentially unlocking the full potential of the food that we eat. Dr. Nora khaldi is the brilliant woman behind Nuritas and today i had the pleasure of diving deep into the weeds with her while she explained just how this technology works, and what it means for human civilization going forward. So without further ado, Dr. Nora Khaldi.
Podcast notes and transcript available here: https://simplebiotechpodcast.com/nora-khaldi-nuritas
-James Ruhle, SimpleBioTechPodcast.com
Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech
If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-simple-biotech-podcast-447043/14-tyler-golato-decentralizing-drug-development-for-the-greater-public-61042385"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to #14 - tyler golato - decentralizing drug development for the greater public good on goodpods" style="width: 225px" /> </a>
Copy